{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T17:19:54Z","timestamp":1789924794740,"version":"4.0.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,8,17]],"date-time":"2012-08-17T00:00:00Z","timestamp":1345161600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s10753-012-9526-6","type":"journal-article","created":{"date-parts":[[2012,8,16]],"date-time":"2012-08-16T08:38:50Z","timestamp":1345106330000},"page":"121-130","source":"Crossref","is-referenced-by-count":35,"title":["Possible Involvement of Toll-Like Receptors in the Pathogenesis of Myasthenia Gravis"],"prefix":"10.1007","volume":"36","author":[{"given":"Yu-Zhong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fa-Fa","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Mei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Bin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,17]]},"reference":[{"key":"9526_CR1","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1172\/JCI29894","volume":"116","author":"BM Conti-Fine","year":"2006","unstructured":"Conti-Fine, B.M., M. Milani, and H.J. Kaminski. 2006. Myasthenia gravis: past, present, and future. The Journal of Clinical Investigation 116: 2843\u20132854.","journal-title":"The Journal of Clinical Investigation"},{"key":"9526_CR2","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1212\/WNL.26.11.1054","volume":"26","author":"JM Lindstrom","year":"1976","unstructured":"Lindstrom, J.M., M.E. Seybold, V.A. Lennon, S. Whittingham, and D.D. Duane. 1976. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology 26: 1054\u20131059.","journal-title":"Neurology"},{"key":"9526_CR3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","volume":"7","author":"W Hoch","year":"2001","unstructured":"Hoch, W., J. McConville, S. Helms, J. Newsom-Davis, A. Melms, and A. Vincent. 2001. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nature Medicine 7: 365\u2013368.","journal-title":"Nature Medicine"},{"key":"9526_CR4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2141.2007.06802.x","volume":"139","author":"AF McGettrick","year":"2007","unstructured":"McGettrick, A.F., and L.A. O'Neill. 2007. Toll-like receptors: key activators of leucocytes and regulator of haematopoiesis. British Journal of Haematology 139: 185\u2013193.","journal-title":"British Journal of Haematology"},{"key":"9526_CR5","doi-asserted-by":"crossref","first-page":"554","DOI":"10.4049\/jimmunol.168.2.554","volume":"168","author":"KA Zarember","year":"2002","unstructured":"Zarember, K.A., and P.J. Godowski. 2002. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. The Journal of Immunology 168: 554\u2013561.","journal-title":"The Journal of Immunology"},{"key":"9526_CR6","doi-asserted-by":"crossref","unstructured":"Takeda, K. and S. Akira. 2007. Toll-like receptors. Current Protocols in Immunology. Chapter 14: Unit 14 12.","DOI":"10.1002\/0471142735.im1412s109"},{"key":"9526_CR7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.smim.2006.12.004","volume":"19","author":"T Kawai","year":"2007","unstructured":"Kawai, T., and S. Akira. 2007. TLR signaling. Seminars in Immunology 19: 24\u201332.","journal-title":"Seminars in Immunology"},{"key":"9526_CR8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1097-2765(00)80136-7","volume":"2","author":"R Medzhitov","year":"1998","unstructured":"Medzhitov, R., P. Preston-Hurlburt, E. Kopp, A. Stadlen, C. Chen, S. Ghosh, and C.A. Janeway Jr. 1998. MyD88 is an adaptor protein in the hToll\/IL-1 receptor family signaling pathways. Molecular Cell 2: 253\u2013258.","journal-title":"Molecular Cell"},{"key":"9526_CR9","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1210\/jc.2007-2185","volume":"93","author":"S Devaraj","year":"2008","unstructured":"Devaraj, S., M.R. Dasu, J. Rockwood, W. Winter, S.C. Griffen, and I. Jialal. 2008. Increased Toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state. The Journal of Clinical Endocrinology and Metabolism 93: 578\u2013583.","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"9526_CR10","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1084\/jem.20052438","volume":"203","author":"M Ehlers","year":"2006","unstructured":"Ehlers, M., H. Fukuyama, T.L. McGaha, A. Aderem, and J.V. Ravetch. 2006. TLR9\/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE. The Journal of Experimental Medicine 203: 553\u2013561.","journal-title":"The Journal of Experimental Medicine"},{"key":"9526_CR11","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1002\/art.10423","volume":"46","author":"RA Zeuner","year":"2002","unstructured":"Zeuner, R.A., K.J. Ishii, M.J. Lizak, I. Gursel, H. Yamada, D.M. Klinman, and D. Verthelyi. 2002. Reduction of CpG-induced arthritis by suppressive oligodeoxynucleotides. Arthritis and Rheumatism 46: 2219\u20132224.","journal-title":"Arthritis and Rheumatism"},{"key":"9526_CR12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1159\/000127433","volume":"14","author":"YN Deng","year":"2007","unstructured":"Deng, Y.N., and W.B. Zhou. 2007. Expression of TLR4 and TLR9 mRNA in Lewis rats with experimental allergic neuritis. Neuroimmunomodulation 14: 337\u2013343.","journal-title":"Neuroimmunomodulation"},{"key":"9526_CR13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000328200","volume":"19","author":"YZ Wang","year":"2012","unstructured":"Wang, Y.Z., Q.H. Liang, H. Ramkalawan, Y.L. Wang, Y.F. Yang, W.B. Zhou, F. Tian, J. Li, and H. Yang. 2012. Expression of Toll-like receptors 2, 4 and 9 in Patients with Guillain-Barr\u00e9 syndrome. Neuroimmunomodulation 19: 60\u201368.","journal-title":"Neuroimmunomodulation"},{"key":"9526_CR14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/08820139.2011.604864","volume":"41","author":"YZ Wang","year":"2011","unstructured":"Wang, Y.Z., Q.H. Liang, H. Ramkalawan, W. Zhang, W.B. Zhou, B. Xiao, F.F. Tian, H. Yang, J. Li, Y. Zhang, and N.A. Xu. 2011. Inactivation of TLR9 by a suppressive oligodeoxynucleotides can ameliorate the clinical signs of EAN. Immunological Investigations 41: 171\u2013182.","journal-title":"Immunological Investigations"},{"key":"9526_CR15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0002-9440(10)62960-4","volume":"167","author":"P Bernasconi","year":"2005","unstructured":"Bernasconi, P., M. Barberis, F. Baggi, L. Passerini, M. Cannone, E. Arnoldi, L. Novellino, F. Cornelio, and R. Mantegazza. 2005. Increased Toll-like receptor 4 expression in thymus of myasthenic patients with thymitis and thymic involution. The American Journal of Pathology 167: 129\u2013139.","journal-title":"The American Journal of Pathology"},{"key":"9526_CR16","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0301-0546(08)75868-3","volume":"36","author":"MT Montero Vega","year":"2008","unstructured":"Montero Vega, M.T., and A. de Andres Martin. 2008. Toll-like receptors: a family of innate sensors of danger that alert and drive immunity. Allergologia et Immunopathologia (Madr) 36: 347\u2013357.","journal-title":"Allergologia et Immunopathologia (Madr)"},{"key":"9526_CR17","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","volume":"55","author":"A Jaretzki 3rd","year":"2000","unstructured":"Jaretzki 3rd, A., R.J. Barohn, R.M. Ernstoff, H.J. Kaminski, J.C. Keesey, A.S. Penn, and D.B. Sanders. 2000. Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology 55: 16\u201323.","journal-title":"Neurology"},{"key":"9526_CR18","first-page":"497","volume":"38","author":"KE Osserman","year":"1971","unstructured":"Osserman, K.E., and G. Genkins. 1971. Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients. The Mount Sinai Journal of Medicine 38: 497\u2013537.","journal-title":"The Mount Sinai Journal of Medicine"},{"key":"9526_CR19","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s004150050585","volume":"247","author":"T Sharshar","year":"2000","unstructured":"Sharshar, T., S. Chevret, M. Mazighi, P. Chillet, G. Huberfeld, C. Berreotta, M. Houfani, and P. Gajdos. 2000. Validity and reliability of two muscle strength scores commonly used as endpoints in assessing treatment of myasthenia gravis. Journal of Neurology 247: 286\u2013290.","journal-title":"Journal of Neurology"},{"key":"9526_CR20","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.clim.2006.04.567","volume":"120","author":"D Rozkova","year":"2006","unstructured":"Rozkova, D., R. Horvath, J. Bartunkova, and R. Spisek. 2006. Glucocorticoids severely impair differentiation and antigen presenting function of dendritic cells despite upregulation of Toll-like receptors. Clinical Immunology 120: 260\u2013271.","journal-title":"Clinical Immunology"},{"key":"9526_CR21","doi-asserted-by":"crossref","first-page":"14277","DOI":"10.1074\/jbc.M709731200","volume":"283","author":"CE McCoy","year":"2008","unstructured":"McCoy, C.E., S. Carpenter, E.M. Palsson-McDermott, L.J. Gearing, and L.A. O'Neill. 2008. Glucocorticoids inhibit IRF3 phosphorylation in response to Toll-like receptor-3 and -4 by targeting TBK1 activation. The Journal of Biological Chemistry 283: 14277\u201314285.","journal-title":"The Journal of Biological Chemistry"},{"key":"9526_CR22","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1136\/ard.2007.086421","volume":"68","author":"MF Roelofs","year":"2009","unstructured":"Roelofs, M.F., M.H. Wenink, F. Brentano, S. Abdollahi-Roodsaz, B. Oppers-Walgreen, P. Barrera, P.L. van Riel, L.A. Joosten, D. Kyburz, W.B. van den Berg, and T.R. Radstake. 2009. Type I interferons might form the link between Toll-like receptor (TLR) 3\/7 and TLR4-mediated synovial inflammation in rheumatoid arthritis (RA). Annals of the Rheumatic Diseases 68: 1486\u20131493.","journal-title":"Annals of the Rheumatic Diseases"},{"key":"9526_CR23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s10875-010-9469-3","volume":"31","author":"A Kessel","year":"2011","unstructured":"Kessel, A., R. Peri, T. Haj, A. Snir, G. Slobodin, E. Sabo, I. Rosner, Y. Shoenfeld, and E. Toubi. 2011. IVIg attenuates TLR-9 activation in B cells from SLE patients. Journal of Clinical Immunology 31: 30\u201338.","journal-title":"Journal of Clinical Immunology"},{"key":"9526_CR24","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/eji.200737187","volume":"38","author":"M Marta","year":"2008","unstructured":"Marta, M., A. Andersson, M. Isaksson, O. Kampe, and A. Lobell. 2008. Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis. European Journal of Immunology 38: 565\u2013575.","journal-title":"European Journal of Immunology"},{"key":"9526_CR25","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1042\/bst0280563","volume":"28","author":"M Muzio","year":"2000","unstructured":"Muzio, M., N. Polentarutti, D. Bosisio, P.P. Manoj Kumar, and A. Mantovani. 2000. Toll-like receptor family and signalling pathway. Biochemical Society Transactions 28: 563\u2013566.","journal-title":"Biochemical Society Transactions"},{"key":"9526_CR26","doi-asserted-by":"crossref","first-page":"10689","DOI":"10.1074\/jbc.274.16.10689","volume":"274","author":"JC Chow","year":"1999","unstructured":"Chow, J.C., D.W. Young, D.T. Golenbock, W.J. Christ, and F. Gusovsky. 1999. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. The Journal of Biological Chemistry 274: 10689\u201310692.","journal-title":"The Journal of Biological Chemistry"},{"key":"9526_CR27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cellimm.2007.04.003","volume":"245","author":"KS Lee","year":"2007","unstructured":"Lee, K.S., C.A. Scanga, E.M. Bachelder, Q. Chen, and C.M. Snapper. 2007. TLR2 synergizes with both TLR4 and TLR9 for induction of the MyD88-dependent splenic cytokine and chemokine response to Streptococcus pneumoniae. Cellular Immunology 245: 103\u2013110.","journal-title":"Cellular Immunology"},{"key":"9526_CR28","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1146\/annurev.immunol.20.100301.064842","volume":"20","author":"AM Krieg","year":"2002","unstructured":"Krieg, A.M. 2002. CpG motifs in bacterial DNA and their immune effects. Annual Review of Immunology 20: 709\u2013760.","journal-title":"Annual Review of Immunology"},{"key":"9526_CR29","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1006\/phrs.2002.0969","volume":"45","author":"C Riccardi","year":"2002","unstructured":"Riccardi, C., S. Bruscoli, and G. Migliorati. 2002. Molecular mechanisms of immunomodulatory activity of glucocorticoids. Pharmacological Research 45: 361\u2013368.","journal-title":"Pharmacological Research"},{"key":"9526_CR30","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mce.2007.04.014","volume":"275","author":"Y Chinenov","year":"2007","unstructured":"Chinenov, Y., and I. Rogatsky. 2007. Glucocorticoids and the innate immune system: crosstalk with the Toll-like receptor signaling network. Molecular and Cellular Endocrinology 275: 30\u201342.","journal-title":"Molecular and Cellular Endocrinology"},{"key":"9526_CR31","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1182\/blood-2010-05-282913","volume":"116","author":"Y Lepelletier","year":"2010","unstructured":"Lepelletier, Y., R. Zollinger, C. Ghirelli, F. Raynaud, R. Hadj-Slimane, A. Cappuccio, O. Hermine, Y.J. Liu, and V. Soumelis. 2010. Toll-like receptor control of glucocorticoid-induced apoptosis in human plasmacytoid predendritic cells (pDCs). Blood 116: 3389\u20133397.","journal-title":"Blood"},{"key":"9526_CR32","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1182\/blood-2006-10-048215","volume":"109","author":"S Bhattacharyya","year":"2007","unstructured":"Bhattacharyya, S., D.E. Brown, J.A. Brewer, S.K. Vogt, and L.J. Muglia. 2007. Macrophage glucocorticoid receptors regulate Toll-like receptor 4-mediated inflammatory responses by selective inhibition of p38 MAP kinase. Blood 109: 4313\u20134319.","journal-title":"Blood"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-012-9526-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10753-012-9526-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-012-9526-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T22:20:20Z","timestamp":1562106020000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10753-012-9526-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,17]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["9526"],"URL":"https:\/\/doi.org\/10.1007\/s10753-012-9526-6","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,17]]}}}